(123)I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms

BACKGROUND: (123)I‐Metaiodobenzylguanidine ((123)I‐MIBG) myocardial scintigraphy is a useful technique to differentiate Parkinson's disease (PD) from atypical parkinsonisms, since it is generally abnormal in PD and normal in the latter. Reduction of myocardial MIBG uptake is a supportive featur...

Descripción completa

Detalles Bibliográficos
Autores principales: Catalan, Mauro, Dore, Franca, Polverino, Paola, Bertolotti, Claudio, Sartori, Arianna, Antonutti, Lucia, Cucca, Alberto, Furlanis, Giovanni, Capitanio, Selene, Manganotti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287155/
https://www.ncbi.nlm.nih.gov/pubmed/34295947
http://dx.doi.org/10.1002/mdc3.13227